Mulmit

LENZ Therapeutics, Inc.LENZ Therapeutics, Inc.

LENZ Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3119,088,000-91,138,000-82,127,000-2.85
2024-12-310-58,610,000-49,769,000-2.34

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-15Guerard Frederic22,100
2026-06-15Scheiner Zachary22,100
2026-06-15George Jeffrey P.22,100
2026-06-15Drapkin Kimberlee C22,100
2026-06-15Thunen Shelley B22,100
2026-06-15RA CAPITAL MANAGEMENT, L.P.22,100
2026-06-15MCCOLLUM JAMES W22,100
2026-03-27George Jeffrey P.5,592
2026-03-27Schimmelpennink Evert B.President, CEO and Secretary28,089
2026-03-27Chevallard Daniel R.Chief Financial Officer7,500
2026-01-02Odrich MarcChief Medical Officer84,200
2026-01-02Odrich MarcChief Medical Officer14,000

8-K events

FiledItems
2026-08-11Results of operations · Financial statements and exhibits
2026-07-02Officer or director change
2026-06-12Submission of matters to a vote
2026-05-11Results of operations · Financial statements and exhibits
2026-03-24Results of operations · Financial statements and exhibits
2026-01-07Results of operations · Financial statements and exhibits
2025-12-12Other events
2025-11-05Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.

한국 시장 대시보드Korea dashboard 미국·글로벌 대시보드US & Global dashboard